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Polychlorinated biphenyls (PCBs) have been 
commercially produced since the 1920s and 
were identified as environmental pollutants 
in 1966 (Beyer and Biziuk 2009). They have 
been recently suspected of causing immu-
notoxic effects because of their similarity to 
dioxins (Larsen 2006). As a model immu-
notoxicant, 2,3,7,8-tetrachlorodibenzo-p-di-
oxin has been shown to disrupt a range of 
maturational processes, depending upon the 
specific timing of exposure (Kerkvliet 2002). 
However, to validate findings from laboratory 
models of immune dysfunction, assessment of 
developmental immunotoxicity in epidemio-
logic studies is needed.
Several studies have reported associations 
between developmental PCB exposures and a 
variety of immune function parameters (Belles-
Isles et al. 2002; Bilrha et al. 2003; Levin 
et al. 2005), with some studies focusing on 
immunoglobulin concentrations at different 
ages (Dewailly et al. 2000; Nagayama et al. 
1998; Weisglas-Kuperus et al. 2000). Among 
immune system properties that are feasible and 
appropriate for population studies, vaccina-
tion responses are of substantial public health 
relevance (van Loveren et al. 1999). The serum 
concentrations of antibodies against vaccine 
toxoids constitute a promising tool for stud-
ies of children, who have been primed by 
standardized doses of foreign antigens at well-
  defined ages as part of routine immunization 
programs. Up-regulation of the T-helper cell 
type 1 functional capacities crucial for vaccine 
antibody responses against T-cell–dependent 
antigens occurs during early postnatal develop-
ment. Accordingly, children may be particu-
larly vulnerable to immunotoxicity caused by 
exposures to environmental chemicals during 
early postnatal development (Dietert 2008). In 
two birth cohorts from the Faroe Islands, we 
recently found that the antibody response to 
diphtheria toxoid was significantly decreased 
at 18 months of age and, in an older cohort, 
that the tetanus toxoid antibody response was 
affected mainly at 7 years of age. The early 
postnatal PCB exposure level was the most 
important predictor of a decreased vaccination 
response (Heilmann et al. 2006).
The Faroe Islands provide a unique 
opportunity to study PCB immunotoxicity. 
Exposures vary widely because of the PCB 
contamination of pilot whale blubber, a tra-
ditional food item favored by many Faroese, 
but not all (Grandjean et al. 2001). To further 
explore the possible effect of PCBs on vaccine 
response, we have now completed follow-up at 
7 years of age of the younger of the two cohorts 
previously examined (Heilmann et al. 2006), 
and invitations were extended to all cohort 
members, thereby securing a study group five 
times larger than the one originally studied.
Methods
Birth cohort and clinical examinations. The 
Faroe Islands constitute a Nordic fishing 
community located in the North Atlantic 
between Shetland and Iceland. A birth 
cohort was formed from consecutive births 
during 1999–2001. Informed consent was 
obtained from a total of 656 mothers in con-
nection with consecutive spontaneous single-
ton births at term.
In the Faroes, the government offers free 
medical care, and childhood vaccinations are 
carried out according to a schedule similar to 
the one used in Denmark. The first childhood 
vaccination, at age 3 months, includes immu-
nization against diphtheria and tetanus, along 
with pertussis, polio, and Haemophilus influ-
enzae type b. Repeat inoculations are given at 
ages 5 and 12 months, and a booster vaccina-
tion against diphtheria and tetanus is given at 
age 5 years.
To examine possible changes in antibody 
responses to vaccinations, the birth cohort 
was prospectively followed until age 7 years. A 
subgroup of these cohort members first came 
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Ba c k g r o u n d: Polychlorinated biphenyls (PCBs) may cause immunotoxic effects, but the detailed 
dose–response relationship and possible vulnerable time windows of exposure are uncertain. In this 
study we applied serum concentrations of specific antibodies against childhood vaccines as sentinels 
of immunotoxicity.
oBjectives: The main objective was to assess the possible dependence of antibody concentrations 
against diphtheria and tetanus toxoids in children with regard to prenatal and postnatal PCB exposures.
Me t h o d s : From a cohort of 656 singleton births formed in the Faroe Islands during 1999–2001, 
children were invited for examination with assessment of serum antibody concentrations at 5 years 
(before and after a booster vaccination) and at 7 years of age. Total PCB concentrations were deter-
mined in serum from ages 5 and 7 years, and data were also available on PCB concentrations in mater-
nal pregnancy serum, maternal milk, and, for a subgroup, the child’s serum at 18 months of age.
re s u l t s: A total of 587 children participated in the examinations at ages 5 and/or 7 years. At age 5 
years, before the booster vaccination, the antidiphtheria antibody concentration was inversely asso-
ciated with PCB concentrations in milk and 18-month serum. Results obtained 2 years later showed 
an inverse association of concentrations of antibodies against both toxoids with PCB concentrations 
at 18 months of age. The strongest associations suggested a decrease in the antibody concentration 
by about 20% for each doubling in PCB exposure. At age 5 years, the odds of an antidiphtheria 
antibody concentration below a clinically protective level of 0.1 IU/L increased by about 30% for a 
doubling in PCB in milk and 18-month serum.
co n c l u s i o n s: Developmental PCB exposure is associated with immunotoxic effects on serum con-
centrations of specific antibodies against diphtheria and tetanus vaccinations. The immune system 
development during the first years of life appears to be particularly vulnerable to this exposure.
key w o r d s : developmental toxicity, environmental exposure, immunotoxicity, methyl  mercury, 
polychlorinated biphenyls. Environ Health Perspect 118:1434–1438 (2010).  doi:10.1289/
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for a follow-up study at 12 and 18 months 
of age (Heilmann et al. 2006), and 116 chil-
dren had sufficient serum for analysis of PCBs. 
Most of these children also participated in 
the subsequent follow-up. The next examina-
tion occurred at approximately 5 years of age, 
before the child had received the booster vac-
cination; 532 cohort members participated and 
successfully provided a serum sample for the 
analyses (81%). A follow-up examination was 
then scheduled for the same children about 
1 month after the booster, as is the routine pro-
cedure in vaccination immunogenicity studies. 
A serum sample was obtained from a total of 
456 children. The birth cohort members were 
again invited when they were about 7.5 years 
of age. Of 464 cohort members (71%) exam-
ined, 43 had not participated 2 years before; 
110 subjects examined at age 5 years did not 
participate at age 7.
The study protocol was approved by the 
ethical review committee serving the Faroe 
Islands and by the institutional review board 
at Harvard School of Public Health.
Exposure assessment. Exposures to marine 
contaminants were assessed from analysis of 
biological samples first obtained from the 
mother at the last antenatal examination at 
week 32 of pregnancy, followed by transitional 
milk samples at postparturition days 4–5, and 
serum samples from the child at successive 
clinical examinations. Serum analyses were 
conducted by gas chromatography with elec-
tron capture detection at the University of 
Southern Denmark. As before (Heilmann 
et al. 2006), the accuracy and reliability of 
the data were ensured by including quality 
control serum samples [excess serum samples 
from the German External Quality Assessment 
Scheme (G-EQUAS) round-robin program as 
well as spiked serum pools] in each analytical 
batch of samples, calibration standards, and 
reagent and serum blanks. Excellent results 
were obtained in intercalibration between 
these laboratories and in the G-EQUAS orga-
nized by the German Society of Occupational 
Medicine. The milk analyses were performed 
by similar methodology by the Department 
of Environmental Health, State Agency for 
Health and Occupational Safety of Schleswig-
Holstein, Germany (Schade and Heinzow 
1998). This laboratory serves as a reference 
laboratory for analyses of environmental 
chemicals in milk. To avoid problems with 
congeners not assessed and concentrations 
below the detection limit, a simplified ΣPCB 
concentration was calculated as the sum of 
congeners CB-138, CB-153, and CB-180 
multiplied by 2 (Grandjean et al. 1995). The 
ΣPCB concentration was expressed in relation 
to the total lipid concentration determined 
using the Cypress Diagnostics kit (Langdorp, 
Belgium). In addition to the ΣPCB concen-
tration, the weighted sum of the three main 
mono-ortho–substituted congeners CB-105, 
CB-118, and CB-156 was calculated using 
toxicity equivalency factors to obtain the 
dioxin equivalent concentration. The analy-
ses also provided the concentrations of the 
pesticide metabolite p,p-dichlorodiphenyl-
dichloroethene (p,p-DDE), hexachloro-
benzene, and β-hexachlorocyclohexane, which 
occurred at lower levels but were detectable in 
almost all samples. However, because of close 
correlations with ΣPCB, these additional ana-
lytes were not examined further. As a meas-
ure of methylmercury exposure, total mercury 
concentrations were measured in cord blood, 
maternal hair at parturition, and hair and 
blood from the children at the clinical exami-
nations (Grandjean et al. 2010).
Vaccines and antibody measurements. All 
infants were vaccinated according to the official 
Danish/Faroese vaccination program. Tetanus 
toxoid and diphtheria toxoid are both classical 
protein antigens that depend on T-helper cells 
for both primary and recall antibody responses. 
Toxoids for the routine childhood vaccinations 
and boosters were from Statens Serum Institut 
(SSI, Copenhagen, Denmark). All children 
received the same amount of diphtheria and 
tetanus toxoid and associated alum adjuvant. 
However, because of changes in the formula-
tion from 1 September 2003, the diphtheria-
tetanus vaccine also contained pertussis antigen 
and (from 1 July 2004) polio; both had previ-
ously been given by injection separately from 
diphtheria-tetanus. None of the vaccines con-
tained mercury-based preservatives.
Serum concentrations of antibodies 
against tetanus toxoids were measured by SSI 
using enzyme-linked immunosorbent assay 
(Hendriksen et al. 1988), whereas antibodies 
against diphtheria toxoids were measured using 
a standard Vero cell–based neutralization assay 
employing 2-fold dilutions of serum samples 
(Miyamura et al. 1974). For both assays, cali-
bration was performed using international and 
local standard antitoxins.
Data analysis. Antibody concentrations 
were first treated as continuous variables, 
because logarithmic transformations reason-
ably approached a Gaussian distribution. 
Associations of PCB exposure with antibody 
concentrations were determined using stan-
dard regression techniques. Antibody con-
centrations were log transformed to obtain 
normally distributed residuals with a homo-
geneous variance. As obligatory covariates, we 
included sex and age only. Both antibody out-
comes obtained after the 5-year booster were 
adjusted for the booster status (i.e., with and 
without other vaccines), and the analysis of the 
immediate post-booster response also included 
the time interval since booster inoculation. 
Because of the clinical importance of protec-
tive antibody concentrations > 0.1 IU/mL, 
odds ratios (ORs) were calculated for the effect 
of PCB exposure on the probability of having 
an antibody concentration below this limit.
PCB exposure parameters were entered 
into the regression models, one at a time, after 
logarithmic transformation. Because of the 
transformations, measures of effects could be 
expressed as the relative change (percent) of 
the outcome variables for each doubling of the 
exposure. Residual plots were used to assess 
the model fit, and the possible significance of 
second- and third-order terms was determined. 
Additional covariates—birth weight, mater-
nal smoking during pregnancy, and duration 
of breast-feeding—were then included to 
determine the possible influence on the PCB 
regression coefficients. Separate regressions 
were also made to estimate the possible impact 
of methylmercury exposure.
The large number of missing values for the 
PCB concentration at 18 months complicated 
the estimation of a possible negative association 
with this exposure. To remedy the problem, we 
used the multiple imputation method (Rubin 
1987) in SAS version 9.1 (SAS Institute Inc., 
Cary, NC, USA). Thus, for children without 
this exposure measure, the PCB concentra-
tion was imputed based on the known associa-
tion with the observed PCB concentrations at 
birth and at 5 years, as well as the length of the 
breast-feeding period. Using this approach, the 
relatively large number of children who missed 
information on the 18-months concentration 
could be included in the regression model. 
Compared with the standard complete case 
analysis, the imputation would be expected to 
lead to a decrease in standard errors of regres-
sion coefficients. All two-tailed p-values < 0.05 
were considered statistically significant.
After the booster vaccination at age 5 years, 
cohort members were examined at different 
intervals. A nonlinear model for the time-
dependent change was therefore generated 
using a cubic spline function, which was used 
to adjust the serum antibody concentrations 
before the regression analyses.
Results
Major characteristics of the 587 cohort mem-
bers contributing serum samples at ages 5 and/
or 7 years are included in Table 1. The pre-
booster concentration of both diphtheria and 
tetanus antibodies correlated well with the 
results at the two subsequent examinations 
(Table 2). Similarly, correlations between log-
transformed tetanus and diphtheria concentra-
tions obtained at the same examination were 
0.45, 0.32, and 0.43 at the three occasions 
(before booster, 1 month after booster, and 
at 7 years, respectively). Although boys had 
higher antibody concentrations than girls and 
also had higher PCB exposures at ages 5 and 
7 years (results not shown), the extended set of 
covariates appeared to cause little potential for 
confounding.Heilmann et al.
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Results of multiple regression analyses with 
adjustment for sex and age indicated a clear 
inverse association between the pre-booster 
diphtheria-specific antibody concentration 
and PCB concentrations in maternal milk 
and in the child’s serum at 18 months of age, 
although the latter comparison was based on 
a much smaller number of subjects than the 
other comparisons. PCB levels measured at 
age 5 years were not associated with the pre-
booster tetanus response at this age (Table 3). 
Further adjustment for additional covariates 
did not materially affect these results.
Serum antibody concentrations after the 
5-year booster vaccination varied according 
to the time interval between the booster vac-
cination and serum collection (Figure 1). Five 
children had a negative interval (i.e., they were 
examined before the booster vaccination) and 
were therefore excluded from the analysis of 
post-booster antibody concentrations. A cubic 
spline function was used for adjustment of the 
data used in these regression analyses. Each 
of the two newer booster vaccinations that 
included additional vaccines were associated 
with lower antibody responses for both teta-
nus and diphtheria (p < 0.05); adjustment for 
the booster type was therefore also included in 
these models as well as for the 7-year data.
Although none of the PCB concentra-
tions at different time points reached statistical 
significance as predictors at the post-booster 
examination, all showed an inverse associa-
tion with the antibody concentrations. Thus, 
doubling of PCB concentrations in maternal 
serum [–7.5%; 95% confidence interval (CI), 
–18.8 to 5.4; p = 0.24], milk (–8.2%; 95% CI, 
–16.9 to 1.5; p = 0.10) and 18-month serum 
(–8.3%; 95% CI, –26.4 to 14.2; p = 0.43) sug-
gested similar relative declines in the diphtheria 
antibody concentration. Although inclusion 
of the additional covariates did not materi-
ally affect these results, the concurrent 5-year 
serum PCB concentration became a significant 
predictor (–11.6%; 95% CI, –19.4 to –3.0; 
p = 0.01) for the diphtheria antibody concen-
tration after adjustment for all covariates.
At age 7 years, six children were excluded 
because they had received an additional booster 
at some point after the routine booster at 5 years 
of age. Children inoculated with the two com-
bination vaccines containing pertussis and/or 
polio showed a lower antibody response toward 
tetanus and diphtheria, and combination 
booster was therefore included as a covariate 
along with sex and age. Again, we saw inverse 
associations with PCB exposure, although not 
as strong as at age 5 years (Table 4). Only the 
serum PCB concentration at age 18 months 
approached statistical significance with regard 
to the decrease in diphtheria antibody concen-
trations, although the response was almost as 
strong with regard to tetanus.
Because of the pronounced association 
with the 18-months serum PCB concentration, 
which was obtained only for about one-fifth of 
the cohort, we conducted further analyses using 
the imputed data. These results strengthened the 
observations, and an inverse association was now 
apparent for tetanus at age 7 years (Table 5).
We further identified the children 
who had antibody concentrations below a 
Table 1. Characteristics, with arithmetic mean ± SD and geometric mean (interquartile range) values, of 
587 birth cohort members examined for serum concentrations of specific vaccine antibodies at ages 5 
and 7 years.
Variable n Result
Maternal age at parturition (years) 587 29.3 ± 5.1
Previous births (none/one/at least two) (%) 587 27.7/32.8/39.5
Smoking during pregnancy (no/yes) (%) 587 71.4/28.6
Gestational age (weeks) 587 39.6 ± 1.3
Birth weight (g) 587 3,721 ± 509
Sex (boys/girls) (%) 587 53.1/46.9
Maternal serum ΣPCB concentration (µg/g lipid) 427 1.25 (0.83–1.90)
Milk ΣPCB concentration (µg/g lipid) 521 1.34 (0.85–2.13)
Duration of exclusive breast-feeding (months) 565 4.6 ± 2.0
Total duration of breast-feeding (months) 569 9.8 ± 6.6
Serum ΣPCB concentration at age 18 months (µg/g lipid) 114 1.17 (0.65–2.11)
Serum ΣPCB concentration at age 5 years (µg/g lipid) 532 1.14 (0.70–1.93)
Serum ΣPCB concentration at age 7 years (µg/g lipid) 487 0.75 (0.43–1.38)
Age at pre-booster 5-year examination (years) 545 4.95 ± 0.06
Age at post-booster examination (years) 461 5.20 ± 0.12
Age at 7-year examination (years)  565 7.53 ± 0.11
Table 2. Geometric mean (and interquartile range) serum antibody concentrations (IU/L) in 587 children 
examined on up to three occasions at ages 5–7 years.
n
Geometric mean 
(interquartile range)
Correlation  
with pre-booster
Tetanus
5 years, pre-booster 529 0.22 (0.10–0.52) (1)
5 years, post-booster 455 35 (16–96) 0.53
7 years 464 1.59 (0.65–4.6) 0.62
Diphtheria
5 years, pre-booster 529 0.12 (0.05–0.40) (1)
5 years, post-booster 455 13 (6.4–26) 0.49
7 years 464 0.68 (0.40–1.60) 0.51
Table 3. Relative change in serum antibody concentrations at age 5 years (before booster vaccination) 
associated with a doubling in developmental exposure to PCBs, as indicated by the concentrations in 
biological samples obtained at different times.
n Change (%) 95% CI p-Value
Tetanus
Pregnancy serum PCB 390 –0.67 –14.4 to 15.3 0.93
Milk PCB 477 –0.89 –11.6 to 11.1 0.88
Child serum PCB, 18 months 107 –8.3 –26.1 to 13.7 0.42
Child serum PCB, 5 years 532 0.6 –8.7 to 10.8 0.91
Diphtheria
Pregnancy serum PCB 390 –12.9 –26.0 to 2.6 0.10
Milk PCB 478 –13.9 –24.2 to –2.4 0.02
Child serum PCB, 18 months 106 –29.3 –45.5 to –8.3 0.01
Child serum PCB, 5 years 533 –6.4 –15.9 to 4.2 0.23
Results are from regression model with adjustment for age and sex.
Figure 1. Time-dependent change in serum anti-
body concentrations against tetanus and diphtheria 
in 455 Faroese children after booster vaccination at 
age 5 years, as modeled by a cubic spline function 
adjusted for sex, age, and booster type. Results are 
shown for girls at age 5.2 years inoculated with a 
booster without additional vaccines.
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clinically protective level of 0.1 IU/mL. As 
anticipated, the highest number was at the 
pre-booster examination at age 5 years, with 
202 (37%) children having a low diphtheria 
concentration and 141 (26%) having a low 
tetanus concentration. The numbers of chil-
dren with inadequate antibody concentrations 
were much less (7% and 4%, respectively) at 
age 7 years, 2 years after booster vaccination. 
The ORs for inadequate antibody concen-
trations associated with a doubling of PCB 
concentrations are shown in Table 6. In gen-
eral, children showing insufficient protection 
against diphtheria had experienced higher 
PCB exposures, as reflected by the concentra-
tions in milk and in serum concentrations at 
ages 18 months or 5 years. Among the limited 
number of children with available exposure 
data from age 18 months, the only two chil-
dren with insufficient protection against diph-
theria at age 7 years had PCB concentrations 
of 3.9 μg/g lipid and 5.3 μg/g lipid—among 
the five highest in the group, a statistically 
significant deviation (p = 0.04) from an expec-
tation of no association.
Mercury exposure parameters showed 
variable associations with the antibody con-
centrations without a clear pattern. The 
strongest negative association was for the hair-
mercury concentration at age 5 years with 
regard to the diphtheria antibody concentra-
tion at age 7 years (–16.3; 95% CI, –31.3 to 
1.9; p = 0.08), but this association was sub-
stantially attenuated when adjusted for PCB 
(–5.6; 95% CI, –23.9 to 17.2; p = 0.60). 
Adjustment for mercury had only a negligible 
effect on the regression coefficients for PCB 
(data not shown).
Discussion
Our study provides support for the notion 
that PCB immunotoxicity has clinical impli-
cations in humans. A major strength is that a 
population-based birth cohort was followed 
for > 7 years, and samples for exposure assess-
ment and vaccine antibody assessments were 
collected at several time points. The results 
showed that the estimated effect on antibody 
concentrations depends on the time window 
that the PCB analysis represents. For example, 
the maternal pregnancy serum concentration, 
which reflects intrauterine PCB exposure, 
showed only a small and not statistically sig-
nificant association with antibody concen-
trations. The same was true for serum PCB 
concentrations determined at the same time 
as antibody assessments, at ages 5 and 7 years, 
that is, in cross-sectional analyses. However, 
the serum PCB at age 18 months tended to 
show the strongest association, thus suggesting 
that body burdens at this age may coincide 
with a highly vulnerable stage of immune sys-
tem development. The average PCB concen-
tration at 18 months was slightly higher than 
the average maternal level during pregnancy 
(Table 1), probably because the former repre-
sents the child’s total accumulation of PCBs 
both from intrauterine exposure and from 
lactational transfer during the full period of 
breast-feeding. In the Faroes, extended breast-
feeding is common, with average exclusive and 
total duration of 4.6 months and 9.8 months 
in this birth cohort (Grandjean et al. 2010). 
Thus, the transfer of PCBs and other potential 
immunotoxicants via human milk (Grandjean 
et al. 1995) is of particular concern because of 
the vulnerability of the immune system during 
the perinatal period.
The findings of this study are in agreement 
with our previous findings from two smaller 
groups of Faroese children, one of which con-
stituted a subgroup of the cohort included 
in the present study (Heilmann et al. 2006). 
At the 18-month examination of a subgroup 
of the cohort presented in this report, the 
diphtheria-specific antibody showed a clear 
decrease associated with increases in the con-
comitant serum PCB concentration. On the 
other hand, our previous study (Heilmann 
et al. 2006) showed an effect of perinatal PCB 
exposure on the tetanus antibody concentra-
tion at 7 years of age, although these chil-
dren had undergone a different schedule of 
vaccinations. Although the amounts of teta-
nus and diphtheria toxoids were the same in 
all booster vaccines applied in the studies, 
polio and pertussis antigens were added to the 
Table 4. Relative change in serum antibody concentrations at age 7 years associated with a doubling in 
developmental exposure to PCBs, as indicated by their concentrations in biological samples obtained at 
different times from members of a Faroese birth cohort.
n Change (%) 95% CI p-Value
Tetanus
Pregnancy serum PCB 329 8.0 –8.9 to 28.0 0.37
Milk PCB 402 –3.6 –15.4 to 9.9 0.58
Child serum PCB, 18 months 67 –11.6 –32.8 to 16.3 0.37
Child serum PCB, 5 years 410 –4.5 –15.0 to 7.3 0.42
Child serum PCB, 7 years 438 –1.3 –11.0 to 9.4 0.80
Diphtheria
Pregnancy serum PCB 329 1.3 –13.3 to 18.5 0.87
Milk PCB 402 –2.0 –13.6 to 11.0 0.75
Child serum PCB, 18 months 67 –17.0 –33.1 to 3.0 0.09
Child serum PCB, 5 years 410 –1.5 –11.7 to 9.8 0.78
Child serum PCB, 7 years 438 1.4 –7.8 to 11.5 0.78
Results are from regression model with adjustment for age, sex, and booster status.
Table 5. Effect on antibody concentrations at ages 5 years (pre-booster) and 7 years associated with PCB 
exposures reflected by the serum concentration at 18 months after multiple imputation to allow for miss-
ing observations among the 587 members of a Faroese birth cohort.
Antibody measure Change (%) 95% CI p-Value
Tetanus
5 years –6.0 –16.5 to 5.7 0.30
7 years –21.7 –33.1 to –8.2 0.003
Diphtheria
5 years –15.4 –25.8 to –3.5 0.01
7 years –18.3 –31.9 to –2.1 0.03
Results are from regression model with adjustment for age and sex; results at 7 years were also adjusted for booster status.
Table 6. ORs (95% CIs) and p-values describing the effect of a doubling exposure concentration on the risk of an antibody concentration below a clinically 
  protective level of 0.1 IU/mL in Faroese birth cohort members examined at ages 5 and 7 years (n = 587).
Antidiphtheria toxoid Antitetanus toxoid
5 years 7 years 5 years 7 years
PCB exposure OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
Pregnancy 1.15 (0.91–1.45) 0.24 0.97 (0.62–1.52) 0.89 1.19 (0.93–1.53) 0.17 0.93 (0.53–1.62) 0.79
Milk 1.34 (1.11–1.61) 0.002 1.03 (0.71–1.50) 0.88 1.11 (0.91–1.36) 0.30 1.06 (0.63–1.79) 0.82
18 monthsa 1.30 (1.08–1.57) 0.006 1.58 (0.88–2.83) 0.12 1.15 (0.92–1.44) 0.22 1.64 (0.96–2.81) 0.07
5 years 1.19 (1.01–1.39) 0.03 1.09 (0.77–1.53) 0.64 1.09 (0.92–1.29) 0.33 1.12 (0.72–1.75) 0.61
7 years — — 1.01 (0.74–1.39) 0.93 — — 1.12 (0.71–1.75) 0.63
Results are from logistic regression model with adjustment for age and sex; results at 7 years were also adjusted for booster status. 
aBased on multiple imputation data.Heilmann et al.
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vaccines during the duration of this study. The 
observed antibody responses to diphtheria and 
tetanus toxoids in the two studies may there-
fore not be fully comparable. Still, in our pre-
vious study, a doubling of the PCB exposure 
at 18 months was associated with a decrease 
in the concomitant antibody response to the 
diphtheria toxoid by 24%, and the decrease 
in the tetanus toxoid antibody at age 7 years 
was 16% for each doubling of the prenatal 
exposure level (Heilmann et al. 2006). These 
responses are similar to the largest effects of 
about 20% observed in this study (Table 5).
The results were clearly affected by the 
time of the examination with regard to the 
antigen stimulation. The antibody concentra-
tions obtained immediately after the booster 
showed a high degree of variability associ-
ated with the time interval before serum col-
lection (Figure 1). Adjustment for the time 
was attempted by including a spline term for 
the time interval since vaccination, but only 
the average time-dependent change could be 
modeled, and the result for each child there-
fore remained somewhat imprecise. Although 
a routine in vaccinology (Siegrist 2008), these 
findings suggest that collection of a sample 
about 1 month after vaccination is not ideal 
in studies of immunotoxicity. Although the 
average peak response occurred after 20 days 
for both tetanus and diphtheria, adverse effects 
on antibody concentration may be masked by 
individual differences in the time-dependent 
change in serum antibody concentrations. 
However, it is noteworthy that, in this case, 
the concurrent PCB concentration showed 
the strongest association with a decreased post-
booster antibody response.
Our results emphasize that PCB exposures 
should be determined at an age that reflects 
the most vulnerable window of development. 
Although several PCB congeners are persis-
tent and have elimination half-lives of sev-
eral years, serum concentrations in children 
change because of the dilution resulting from 
an expanded lipid compartment (Grandjean 
et al. 2008). Age 18 months appears to repre-
sent an approximate peak age with regard to 
immune system vulnerability, and the pres-
ent data therefore suggest that representative 
serum samples should be secured between 
ages 1 and 2 years for future studies of human 
immunotoxicity.
Among possible weaknesses of this study, 
serum collection that was incomplete at age 
18 months appeared to be of the greatest 
relevance to the findings. However, partial 
adjustment for the missing data was achieved 
through statistical modeling involving multiple 
imputations. This method relies on the lin-
ear association between log-transformed PCB 
concentrations at different ages and assumes 
that PCB values are missing at random. 
Although some deviation from this assumption 
is possible, the multiple imputation method is 
less likely to be biased than the standard com-
plete case analysis (Rubin 1987). Although 
several potential covariates were examined 
and included in multiple regression analyses, 
few of them played any role at all. As previ-
ously reported (Heilmann et al. 2006), most 
of the variability in serum antibody concen-
trations is unexplained, and compared with 
the covariates, PCB exposure was a remark-
ably strong predictor. The Faroese population 
is also exposed to contaminants other than 
PCBs, such as p,p-DDE, hexachlorobenzene, 
and β-hexachlorocyclohexane. Because they 
correlate with PCB, this study could not assess 
whether they played any independent role. 
However, they occurred in lower concentra-
tions than the PCBs, and available data sug-
gest that any immunotoxicity is likely to be 
relatively weak (Barnett et al. 1987; Das et al. 
1990). Methylmercury exposure did not seem 
to affect the outcomes.
The implications of the results need to 
take into account that antibody responses of 
normal children to routine prophylactic vacci-
nations can vary substantially, but the reasons 
for this wide variation are poorly understood. 
An antibody concentration > 0.1 IU/mL is 
considered essential to achieve full long-term 
protection in accordance with the public 
health purpose of routine vaccinations. The 
clinical importance of our findings is, there-
fore, that the PCB exposure may increase the 
risk of a child not being protected against 
diphtheria and possibly tetanus, despite a full 
schedule of vaccinations.
These results should also be considered 
in light of the range of immune processes 
involved in antibody formation, including 
antigen presentation, T-lymphocyte func-
tion, and B-lymphocyte function (Dietert 
2008; van Loveren et al. 1999). Because of 
the involvement of several key components of 
the immune system, antibody concentrations 
triggered by standardized antigen stimula-
tions may reflect the overall efficacy of the 
immune system in relation to infection. The 
PCB-associated decreases in antibody con-
centrations may therefore also relate to poten-
tial adverse consequences of immune system 
deficits beyond the protection against the two 
specific bacteria.
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